How should I manage a patient with migraine and functional neurological disorder who presents with weakness and a positive Hoover sign on neurologist examination?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of FND with Weakness and Positive Hoover Sign

This patient requires multidisciplinary rehabilitation centered on occupational therapy and physical therapy using a biopsychosocial framework, with concurrent appropriate migraine management, as the positive Hoover sign confirms the functional nature of the weakness and guides treatment away from traditional neurological rehabilitation approaches. 1

Immediate Management Framework

Diagnosis Confirmation and Patient Education

The positive Hoover sign is a positive clinical sign that confirms FND diagnosis—this is not a diagnosis of exclusion 1. The neurologist's examination has already established this, which is critical for moving forward with appropriate treatment.

Key educational points to discuss with the patient:

  • FND is a real, common, and disabling condition causing neurological symptoms outside their control
  • Symptoms result from potentially reversible miscommunication between brain and body
  • The diagnosis was made using positive clinical signs (the Hoover sign in this case), not by ruling out other conditions
  • FND can coexist with other neurological conditions like migraine 1
  • Self-directed attention worsens symptoms; redirecting attention can temporarily reduce them
  • The body's stress response influences nervous system functioning and therefore FND symptoms

Core Treatment Strategy

Occupational therapy should be the primary rehabilitation intervention 1. The approach must differ fundamentally from standard neurological rehabilitation:

Essential OT components:

  • Retraining normal movement within functional activities (not isolated muscle strengthening)
  • Graded reintroduction to daily activities with patient-set goals in their own words
  • Self-management strategy development to establish internal locus of control
  • 24-hour approach: implementing rehabilitation strategies throughout daily routine
  • Anxiety management techniques
  • Reestablishment of structure and routine 1

Critical Pitfall to Avoid

Do not use typical neurorehabilitation strategies designed for structural neurological conditions like stroke. FND requires a distinct approach focusing on function rather than impairment, with emphasis on self-management and understanding that recovery follows a pattern of symptom remission and exacerbation 1.

Migraine Management

Treat the migraine aggressively and appropriately, as migraine is highly prevalent in FND patients and may be a predisposing factor that can predate FND by up to 10 years 2, 3. Importantly, treating migraine may improve functional symptoms 2.

Preventive Therapy Options (in order of recommendation strength):

Strong recommendations:

  • Candesartan or telmisartan 4
  • Erenumab, fremanezumab, or galcanezumab 4

Weaker but reasonable options:

  • Topiramate (also helps chronic migraine) 4
  • Propranolol 4
  • Valproate 4

Acute Treatment:

  • First-line: Eletriptan, rizatriptan, sumatriptan (oral/subcutaneous), or sumatriptan-naproxen combination 4
  • Alternative: Aspirin-acetaminophen-caffeine combination 4

Critical Medication Consideration

Screen for medication overuse headache given the patient has both migraine and FND. High-risk factors include:

  • Headache frequency ≥7 days/month
  • Migraine diagnosis (already present)
  • History of anxiety or depression (common in FND)
  • Physical inactivity 4

Practical Implementation

Week 1-2:

  • Provide structured education about FND and migraine relationship
  • Initiate migraine preventive therapy
  • Begin OT assessment focusing on functional activities, not isolated weakness
  • Establish patient-directed goals

Weeks 3-12:

  • Supervised exercise and functional activity practice through OT
  • Progressive reduction of attention to weakness
  • Development of self-management strategies
  • Continue migraine optimization

Avoid:

  • Prolonged use of adaptive equipment (crutches, wheelchairs) unless absolutely necessary—these can cause secondary problems like shoulder pain and muscle deconditioning 1
  • Excessive focus on the weakness itself rather than functional activities
  • Time-dependent rigid goals (recovery is often non-linear)

Prognosis

Studies show promising outcomes with this approach: improvements in physical function scales and quality of life both immediately after treatment and at 12-25 month follow-up 1. The combination of appropriate migraine treatment with FND-specific rehabilitation addresses both conditions' contributions to disability 2, 3.

Related Questions

How can migraine headaches lead to functional neurological disorder (FND)?
What symptoms of functional neurological disorder (FND) can be triggered by migraine attacks?
Do intermittent finger tremor, cognitive fog, impaired memory encoding, anomia, and dysarthria indicate migraine, functional neurological disorder, or another underlying condition?
What is the diagnosis and treatment for a patient with a mute plantar response and a positive Hoover sign, suggesting a possible upper motor neuron lesion?
What is a positive Hoover sign, and how does it apply to a migraine patient with brain fog and word‑finding difficulty?
Do Johns Hopkins, Mayo Clinic, Memorial Sloan Kettering, and MD Anderson meet the criteria for optimal stage IV prostate cancer care, including on‑site genomic profiling, PSMA PET imaging, and availability of 177Lu‑PSMA‑617 radioligand therapy and relevant clinical trials?
What is a positive Hoover sign, and how does it apply to a migraine patient with brain fog and word‑finding difficulty?
Does the Medical University of South Carolina (MUSC) in South Carolina offer on‑site genomic profiling, PSMA PET imaging, and 177Lu‑PSMA‑617 therapy for stage IV prostate cancer patients?
Do granulocyte colony-stimulating factor (G‑CSF) or blood transfusion cause an increase in eosinophil or lymphocyte counts?
In castration-sensitive metastatic prostate cancer, is orchiectomy or medical androgen-deprivation therapy with external-beam radiation more effective?
What is the recommended management of uremic pruritus in non‑dialysis patients receiving hospice care?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.